Announcements Trials
Browse Landscape

Phase

Phase NA 5

Status

Completed 5

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5CNS 4Other hematologic neoplasm 3Lymphoid 2Gynecologic 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Plasma cell 1

Conditions

Breast Neoplasms 5Depression 1Anxiety Disorders 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Psychosocial Intervention × Breast × Clear all
NCT02439437 2020-05-01

Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain

Duke University

Phase NA Completed
28 enrolled
Breast

Breast Neoplasms

NCT02189278 2018-10-03

Improving Adherence to Recommended Surveillance in Breast Cancer Survivors

Duke University

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

NCT01256008 2015-05-01

Intervention Study of Depression in Breast Cancer Patients

Wenzhou Medical University

Phase NA Completed
392 enrolled 10 charts
Breast

Anxiety Disorders, Breast Neoplasms, Depression

NCT01368380 2015-02-26

HIH

University of Southern Denmark

Phase NA Completed
198 enrolled
Breast

Breast Neoplasms

NCT01342302 2013-04-10

OPIC

Sunnybrook Health Sciences Centre

Phase NA Completed
20 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡